126 related articles for article (PubMed ID: 38556985)
21. Amorphous NiB@IrO
Wang Q; Shaik F; Lu X; Zhang W; Wu Y; Qian H; Zhang W
Acta Biomater; 2023 Jan; 155():575-587. PubMed ID: 36374661
[TBL] [Abstract][Full Text] [Related]
22. Engineering Nanozymes for Tumor Therapy via Ferroptosis Self-Amplification.
Liu S; Wei Y; Liang Y; Du P; Lei P; Yu D; Zhang H
Adv Healthc Mater; 2024 Apr; ():e2400307. PubMed ID: 38573778
[TBL] [Abstract][Full Text] [Related]
23. Nanocatalytic theranostics with intracellular mutual promotion for ferroptosis and chemo-photothermal therapy.
Zhang M; Chen Y; Wang Q; Li C; Yuan C; Lu J; Luo Y; Liu X
J Colloid Interface Sci; 2024 Mar; 657():619-631. PubMed ID: 38071811
[TBL] [Abstract][Full Text] [Related]
24. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
25. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
26. Remodeling the Tumor Microenvironment with Core-Shell Nanosensitizer Featuring Dual-Modal Imaging and Multimodal Therapy for Breast Cancer.
Hou YK; Zhang ZJ; Li RT; Peng J; Chen SY; Yue YR; Zhang WH; Sun B; Chen JX; Zhou Q
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2602-2616. PubMed ID: 36622638
[TBL] [Abstract][Full Text] [Related]
27. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
28. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment.
Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ
Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853
[TBL] [Abstract][Full Text] [Related]
29. 2D Catalytic Nanozyme Enables Cascade Enzyodynamic Effect-Boosted and Ca
Wang Z; Wang X; Dai X; Xu T; Qian X; Chang M; Chen Y
Adv Mater; 2024 Jun; 36(24):e2312316. PubMed ID: 38501540
[TBL] [Abstract][Full Text] [Related]
30. A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer.
Zeng L; Ding S; Cao Y; Li C; Zhao B; Ma Z; Zhou J; Hu Y; Zhang X; Yang Y; Duan G; Bian XW; Tian G
ACS Nano; 2023 Jul; 17(14):13195-13210. PubMed ID: 37256771
[TBL] [Abstract][Full Text] [Related]
31. GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification.
Yang S; Wu Y; Zhong W; Chen R; Wang M; Chen M
Adv Mater; 2024 Jan; 36(2):e2304098. PubMed ID: 37689975
[TBL] [Abstract][Full Text] [Related]
32. Facile Synthesis of Fe
Qi C; Wang W; Wang P; Cheng H; Wang X; Gong B; Xie A; Shen Y
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807249
[TBL] [Abstract][Full Text] [Related]
33. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS.
Wang L; Wang C; Li X; Tao Z; Zhu W; Su Y; Choi WS
Cell Mol Biol Lett; 2023 May; 28(1):36. PubMed ID: 37131152
[TBL] [Abstract][Full Text] [Related]
34. Key Modulation of ROS and HSP for Effective Therapy Against Hypoxic Tumor with Multifunctional Nanosystem.
Ma B; Zhao Y; Liu X; Huo M; Wang J; Ma J; Zhang Y; Qin C
Int J Nanomedicine; 2023; 18():6829-6846. PubMed ID: 38026539
[TBL] [Abstract][Full Text] [Related]
35. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
36. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
[TBL] [Abstract][Full Text] [Related]
37. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
[TBL] [Abstract][Full Text] [Related]
38. Improved Immune Response for Colorectal Cancer Therapy Triggered by Multifunctional Nanocomposites with Self-Amplifying Antitumor Ferroptosis.
Lin X; Chen H; Deng T; Cai B; Xia Y; Xie L; Wang H; Huang C
ACS Appl Mater Interfaces; 2024 Mar; 16(11):13481-13495. PubMed ID: 38456402
[TBL] [Abstract][Full Text] [Related]
39. In Situ Imaging of Cellular Reactive Oxygen Species and Caspase-3 Activity Using a Multifunctional Theranostic Probe for Cancer Diagnosis and Therapy.
Wang K; Zhang F; Wei Y; Wei W; Jiang L; Liu Z; Liu S
Anal Chem; 2021 Jun; 93(22):7870-7878. PubMed ID: 34038094
[TBL] [Abstract][Full Text] [Related]
40. GSH/APE1 Cascade-Activated Nanoplatform for Imaging Therapy Resistance Dynamics and Enzyme-Mediated Adaptive Ferroptosis.
Yue R; Zhou M; Li X; Xu L; Lu C; Dong Z; Lei L; Liu H; Guan G; Liu Q; Zhang XB; Song G
ACS Nano; 2023 Jul; 17(14):13792-13810. PubMed ID: 37458417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
